# Dose Escalation Using Hypoxia-adjusted Radiotherapy

> **NCT06087614** · PHASE2 · RECRUITING · sponsor: **Rajiv Gandhi Cancer Institute & Research Center, India** · enrollment: 124 (estimated)

## Conditions studied

- Head and Neck Squamous Cell Carcinoma

## Interventions

- **RADIATION:** DE-HyART
- **RADIATION:** Standard Arm
- **DRUG:** Cisplatin injection
- **RADIATION:** Standard fractionation (Radiation Oncology preference)

## Key facts

- **NCT ID:** NCT06087614
- **Lead sponsor:** Rajiv Gandhi Cancer Institute & Research Center, India
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-08
- **Primary completion:** 2028-04
- **Final completion:** 2028-04
- **Target enrollment:** 124 (ESTIMATED)
- **Last updated:** 2025-01-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06087614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06087614, "Dose Escalation Using Hypoxia-adjusted Radiotherapy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06087614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*